In this third part of our investor survey, we asked some of the UK?s leading fund managers which sectors or stocks they thought were the most promising for 2024.The responses were as varied as they were thought-provoking, with only a couple of managers singling out technology stocks.As before we would like to thank all those who took part for sharing their views, and we hope readers enjoy them. WH

Stocks in London ended lower on Monday, feeling the pressure of an expected interest rate hike in the UK on Thursday, as well as disappointing growth expectations for China.The FTSE 100 index closed down 54.24 points, or 0.7% at 7,588.48 on Monday. The FTSE 250 ended down 176.60 points, or 0.9%, at 18,854.29. The AIM All-Share closed down 2.48 points, or 0.3%, at 790.11.The Cboe UK 100 ended down

-Multi-year agreement with Intuitive Surgical-Significant commercial opportunity-Current year off to strong startMinimally invasive electrosurgical devices company Creo Medical (CREO:AIM) provided a positive update on results to December 2021 and announced a collaboration with the world's leading surgical robotics company.Creo Medical has signed a multi-year agreement with US listed Intuitive Surg

Creo Medical (CREO:AIM) is aiming to bring forward its US commercial launch plans after its medical device Speedboat RS2 was approved by the US Food and Drug Administration in only 49 days.The approval for the disposable device for the treatment of colorectal cancer is six months ahead of schedule and could bode well for future product launches.

Medical device company Creo Medical (CREO: AIM) has received a welcome boost on its first day of trading on AIM, as the stock gains approximately 5% to 80p. Investors are clearly upbeat despite the obvious risks.The manufacturer of minimally invasive products, such as endoscopes equipped with a light and camera that are designed to access the gastrointestinal tract (GI). Endoscopes generally go do

I'll not re-hash today's trading update from NCC (NCC), you can read it for yourself here, but suffice to say, it was not what the market expected. Nor will I lie, this blind-sided me too, an arrow through the heart of my Valentine's day article.Perhaps most interesting is the number of seemingly-unrelated issues that have coalesced into a stuttering end to the year. What this seems to imply is th